492 related articles for article (PubMed ID: 33422062)
1. An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells.
Abedi F; Davaran S; Hekmati M; Akbarzadeh A; Baradaran B; Moghaddam SV
J Nanobiotechnology; 2021 Jan; 19(1):18. PubMed ID: 33422062
[TBL] [Abstract][Full Text] [Related]
2. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
3. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W
Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637
[TBL] [Abstract][Full Text] [Related]
4. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate.
Salehi R; Rasouli S; Hamishehkar H
Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723
[TBL] [Abstract][Full Text] [Related]
5. pH and Reduction Dual-Responsive Nanogels as Smart Nanocarriers to Resist Doxorubicin Aggregation.
Maruf A; Milewska M; Lalik A; Wandzik I
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144713
[TBL] [Abstract][Full Text] [Related]
6. Dual responsive magnetic composite nanogels for thermo-chemotherapy.
Indulekha S; Arunkumar P; Bahadur D; Srivastava R
Colloids Surf B Biointerfaces; 2017 Jul; 155():304-313. PubMed ID: 28448900
[TBL] [Abstract][Full Text] [Related]
7. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.
Zhao X; Chen Q; Liu W; Li Y; Tang H; Liu X; Yang X
Int J Nanomedicine; 2015; 10():257-70. PubMed ID: 25565818
[TBL] [Abstract][Full Text] [Related]
8. Hierarchical bioresponsive nanocarriers for codelivery of curcumin and doxorubicin.
Lin JT; Ye QB; Yang QJ; Wang GH
Colloids Surf B Biointerfaces; 2019 Aug; 180():93-101. PubMed ID: 31035057
[TBL] [Abstract][Full Text] [Related]
9. Zwitterionic Polymer Micelles with Dual Conjugation of Doxorubicin and Curcumin: Synergistically Enhanced Efficacy against Multidrug-Resistant Tumor Cells.
Zhao G; Sun Y; Dong X
Langmuir; 2020 Mar; 36(9):2383-2395. PubMed ID: 32036662
[TBL] [Abstract][Full Text] [Related]
10. Preparation of thermo/redox/pH-stimulative poly(N-isopropylacrylamide-co-N,N'-dimethylaminoethyl methacrylate) nanogels and their DOX release behaviors.
Gao D; Duan L; Wu M; Wang X; Sun Z; Zhang Y; Li Y; He P
J Biomed Mater Res A; 2019 Jun; 107(6):1195-1203. PubMed ID: 30650226
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment responsive nanogels as a smart triggered release platform for enhanced intracellular delivery of doxorubicin.
Kumar P; Behl G; Kaur S; Yadav N; Liu B; Chhikara A
J Biomater Sci Polym Ed; 2021 Feb; 32(3):385-404. PubMed ID: 33054642
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
13. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
Baghbani F; Moztarzadeh F
Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anticancer potency by thermo/pH-responsive PCL-based magnetic nanoparticles.
Hosseini Sadr S; Davaran S; Alizadeh E; Salehi R; Ramazani A
J Biomater Sci Polym Ed; 2018 Feb; 29(3):277-308. PubMed ID: 29212412
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
18. Exogenous vitamin C triggered structural changes of redox-activated dual core-crosslinked biodegradable nanogels for boosting the antitumor efficiency.
Zhu Y; He Y; Su T; Li C; Cai S; Wu Z; Huang D; Zhang X; Cao J; He B
J Mater Chem B; 2020 Jun; 8(23):5109-5116. PubMed ID: 32412025
[TBL] [Abstract][Full Text] [Related]
19. Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach.
Tefas LR; Sylvester B; Tomuta I; Sesarman A; Licarete E; Banciu M; Porfire A
Drug Des Devel Ther; 2017; 11():1605-1621. PubMed ID: 28579758
[TBL] [Abstract][Full Text] [Related]
20. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]